Tele: 561.316.3330
Breaking Medical Device News

Monday, September 27, 2021
HomeVisionairy HealthVisionairy Health Secures CE Marking for its AI-Based X-Ray Triage Tool

Visionairy Health Secures CE Marking for its AI-Based X-Ray Triage Tool

Visionairy Health, is a Health-tech AI company. Today they announced they obtained CE Marking for X1, its artificial intelligence (AI) based chest x-ray triage and prioritization product. X1 is a state-of-the-art medical device that uses deep learning to analyze chest x-rays, flagging those images that are suggestive of the presence of one or more of 15 pre-specified findings (including tuberculosis, pneumothorax, and lung nodules).

Visionairy Health notes it has been trained using hundreds of thousands of chest x-rays from dozens of geographical locations. X1 is PACS agnostic and can be easily integrated with existing radiology software. The software’s notifications act as a secondary check in parallel to physicians’ independent assessment to ensure that imaging studies with any prespecified findings are brought to their immediate attention.

“We’re excited to receive CE Marking, as this allows us to deploy X1 in Europe and delve into the other markets in the Middle East, Africa, and Asia as a next step,” says Moustafa Amin, Co-founder and CEO of Visionairy Health.

Visionairy Health has partnerships with large healthcare providers in those regions and they are eager to use X1. Dr. Hesham Zaki, VP of Radiology and Informatics at GNP Hospitals Group, an early partner of VH, says: “At GNP, we process a large number of chest x-rays every day, so we are looking forward to using the X1 triage tool. With X1, our physicians can be more efficient and focus on scans that require their immediate attention.”

X1 is part of a suite of AI products being developed by VH to help clinicians manage the ever-increasing volume of diagnostic radiography in hospitals and clinics around the world. The CE marking of X1 paves the way for its commercial launch in most regions of the world

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

ProSomnus® Sleep Technologies Adds John E. Remmers, MD, to Leadership Team

Dr. John E. Remmers will provide expert medical and strategic guidance on a range of initiatives, including research and development, regulatory clearances, company strategy, medical education, and clinical investigations.

Nanox to Announce Zebra Medical Vision Secures 8th 510K FDA Clearance for its Coronary Artery Calcium (CAC) Solution as Part of Its Population Health Offering

On August 10th, 2021 Nanox announced that it had entered into an acquisition agreement via merger with Zebra Medical Vision LTD.

Christopher Joyce Joins Miach Orthopaedics as VP & CFO

Christopher Joyce has joined as vice president and chief financial officer, and Kevin Sidow has been appointed to the company’s board of directors.

NGMedical GmbH Receives FDA Clearance for Its AM Titanium Lumbar Interbody BEE® PLIF

The BEE® PLIF cage has been created to benefit from additive manufacturing features. The purposefully designed honeycomb endplate design reduces the risk of subsidence, while allowing fusion.

Recombinant Technologies is Raising Capital to Roll Out a Game Changing Alzheimer’s Treatment

Recombinant Technologies is focused on treating the root cause of Alzheimer's Disease delivering a huge improvement in the quality of life of those afflicted.

Tyber Medical Reaches Agreement to Acquire CatapultMD

Once the acquisition is complete, Tyber Medical will own and operate a combined 100,000-square feet of manufacturing space between its Pennsylvania headquarters and Florida-based facilities.

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

By using this website you agree to accept Medical Device News Magazine Privacy Policy